Back to Stakeholders
Categories

2 domains / 4 areas / 2 specializations

Care Delivery & Psychedelic Facilitation
Care Delivery & Psychedelic Facilitation
Psychedelic Healthcare ImplementationHealth Economists
Government, Policy & Advocacy
Government, Policy & Advocacy
Public Sector Health & Drug GovernanceHealth Technology Assessment Agencies

Scottish Medicines Consortium (SMC)

Scotland’s public HTA body issuing medicine acceptance guidance, including esketamine (Spravato) advice.

Reimbursement & Market Access Snapshot

Health Economists

Service Model

HTA / Value Assessment Body

Jurisdiction

Subnational / State-Level

Coverage

1 country

Last Verified

Apr 8, 2026

Focus Areas

HTA Evidence AppraisalCost-Effectiveness ModelingCoverage Policy DesignFormulary & Access Criteria

Evidence Requirements

Clinical Efficacy EndpointsComparative EffectivenessCost-EffectivenessBudget ImpactPatient-Reported Outcomes

Market Access Notes

SMC provides rapid HTA-style appraisals and advice for NHS Scotland; current profiling is based on official medicines-advice listings with psychedelic-relevant content monitored.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Primary Access Link

Source Evidence

SMC - Medicines Advice

https://www.scottishmedicines.org.uk/medicines-advice/

SMC - Medicines Advice Search (Esketamine)

https://www.scottishmedicines.org.uk/medicines-advice/?keywords=esketamine

Quick Facts

Website
Visit